Compare ALK & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALK | GRFS |
|---|---|---|
| Founded | 1932 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.4B |
| IPO Year | 2003 | N/A |
| Metric | ALK | GRFS |
|---|---|---|
| Price | $47.32 | $7.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 2 |
| Target Price | ★ $62.92 | $10.15 |
| AVG Volume (30 Days) | ★ 3.2M | 569.0K |
| Earning Date | 04-20-2026 | 07-28-2022 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,426,000,000.00 | N/A |
| Revenue This Year | $11.19 | $4.49 |
| Revenue Next Year | $5.11 | $6.42 |
| P/E Ratio | ★ N/A | $18.67 |
| Revenue Growth | ★ 8.09 | N/A |
| 52 Week Low | $33.03 | $7.26 |
| 52 Week High | $65.35 | $11.14 |
| Indicator | ALK | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 61.60 | 47.21 |
| Support Level | $46.38 | $7.64 |
| Resistance Level | $47.60 | $8.24 |
| Average True Range (ATR) | 2.10 | 0.18 |
| MACD | 0.30 | -0.01 |
| Stochastic Oscillator | 89.07 | 44.02 |
Alaska Air Group Inc operates two airlines, Alaska and Horizon, in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements. The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary, and Mileage Plan passenger revenue.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.